Hyperscalers Are Spending $600 Billion On AI. Goldman Sachs’ AI Bear Case Is Right On Spending, Wrong On Math.

(Nasdaq: BNGO) reported that 28 publications describing the utility of optical genome mapping (OGM) for analysis of rare diseases were released in Q1 2026, representing an approximately 56% increase ...

Executives have been pushing AI for years. But leadership-led workplace culture may be preventing effective adoption, ...

ICE agents leave a residence after knocking on the door on Jan. 28, 2026 in Minneapolis, Minnesota. The U.S. Department of Homeland Security continues its immigration enforcement operations after two ...

If you’re encountering this, there’s a good chance you might be the test case,” one employer-side attorney told HR Dive.

New BPEI preclinical data address treatment protocol, corneal biochemical environment, fungal resistance mechanism, MRSA biofilm inhibition, and ...

After failing to convince a state court it had been libeled, a church built around psilomethoxin goes to Business Court ...

Companies are chasing tenfold AI gains, but many projects are failing fast. We break down the real risks and show you how to ...

A class at Duke University's Fuqua School of Business uses an AI agent to record student conversations, analyze their ...

For decades, the insurance industry moved at its own deliberate pace - a world of actuarial tables, paper applications, and ...

The fentanyl crisis is one of the most urgent public health and national security concerns facing the United States.

Scientists have zeroed in on a widely-used weed killer that could be tied to a historic rise in young colon cancer cases.